Who Paid My Doc
Anavip
Biological antivenom
NDC 66621-0790-2
General payments
$7,761
Research payments
$0
Through program year 2019, $7,761 in general payments and $0 in research payments were reported against Anavip (antivenom).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | General | $7,761 | 71 |
Breakdown
The top 5 of 60 recipients; each share is of general payments naming this product in 2019.
The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.
The top 5 of 14 states; each share is of general payments naming this product in 2019 where a state was reported.
Records
71 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.